B

Baylor Scott and White Health | Soltero Cardiovascular Research Center

Research site

(Unclaimed)

Location

621 N Hall Street, Ste 530, Dallas, Texas, United States of America

Site insights

Top conditions

Top treatments

sodium

EMPagliflozin

Daratumumab

Evolocumab

Apixaban

DUR-928

Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting

Coronary Heart Disease (CHD)

Drug: Evolocumab

Drug: Placebo

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Placebo

Drug: Inclisiran sodium 300 mg

The Merit WRAPSODY AV Access Efficacy Study (WAVE)

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlus...

Active, not recruiting

Venous Occlusion

Venous Stenosis

Device: PTA

Device: Merit WRAPSODY Endovascular Stent Graft